|
|
|
| Visual analysis of anti-Müllerian hormone in polycystic ovary syndrome based on CiteSpace and VOSviewer |
| ZHANG Ming1 KUANG Hongying2 ZHAO Shanshan1 |
1.Graduate School, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China;
2.Ward Two, Department of Gynecology, the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China
|
|
|
|
Abstract Objective To analysis of anti-Müllerian hormone (AMH) in polycystic ovary syndrome (PCOS) based on CiteSpace and VOSviewer. Methods Related literature on AMH in the field of PCOS from CNKI, VIP, Wanfang, and China Biomedical Literature Database were searched, the search time was from January 2003 to October 2022. VOSviewer 1.6.18 and CiteSpace 6.1.R3 were used to map the annual publication volume of AMH in the field of PCOS, author cooperation, institutional cooperation, and visual knowledge map of keyword co-occurrence, clustering, time line, and emergence analysis. Results A total of 780 literatures were retrieved, and the number of published papers showed an overall increasing trend. A total of 116 core authors and 40 core institutions were selected, and the density of institutional cooperation map was 0.000 3. A total of 242 keywords were included in the atlas, and 12 clustering, and 27 high-frequency keywords were obtained. Conclusion The research on AMH in the field of PCOS has received continuous attention, which is closely related to the clinical manifestations, patient demands, diagnostic criteria, and treatment methods of PCOS.
|
|
|
|
|
|
[1] Doherty DA，Newnham JP，Bower C，et al. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring [J]. Obstet Gynecol，2015，125（6）：1397-1406.
[2] Balen AH，Morley LC，Misso M，et al. The management of anovulatory infertility in women with polycystic ovary syndrome：an analysis of the evidence to support the development of global WHO guidance [J]. Hum Reprod Update，2016， 22（6）：687-708.
[3] Pigny P，Jonard S，Robert Y，et al. Serum anti-Mullerian hor- mone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome[J]. J Clin Endocrinol Metab，2006，91（3）：941-945.
[4] 李萍，谈珍瑜，谢小兵，等.AMH和INHB用于诊断多囊卵巢综合征及其疗效评估[J].中华检验医学杂志，2017， 40（5）：391-395.
[5] 贺侠琴，孙桂荣，王汝琨，等.血清抗缪勒管激素与性激素联合检测对多囊卵巢综合征的诊断价值[J].中华检验医学杂志，2018，41（6）：456-461.
[6] 丁学东.文献计量学基础[M].北京：北京大学出版社，1993.
[7] 王利娟，阮祥燕，崔亚美，等.多囊卵巢综合征不同表型的血清抗苗勒管激素水平特征的分析[J].首都医科大学学报，2016，37（4）：444-448.
[8] 金婧，阮祥燕，华琳，等.多囊卵巢综合征合并卵巢储备功能低下病人的内分泌特征[J].首都医科大学学报，2017， 38（4）：515-520.
[9] 杨瑜，阮祥燕.抗苗勒管激素暴露对女性及其子代健康影响的研究进展[J].中国临床医生杂志，2022，50（9）：1037- 1040.
[10] 豆竹丽，阮祥燕，鞠蕊，等.综合干预后多囊卵巢综合征不孕患者应用来曲唑促排卵的临床效果[J].首都医科大学学报，2020，41（4）：525-529.
[11] 李琳，翁梅英，陈晓莉，等.抗苗勒氏管激素在多囊卵巢综合征中的诊断价值初探[J].实用妇产科杂志，2009， 25（11）：658-661.
[12] 李轶，谭嘉琦，麦卓瑶，等.抗苗勒管激素水平对多囊卵巢综合征辅助生殖治疗结局的预测价值[J].中华妇产科杂志，2018，53（1）：23-30.
[13] 钟兴明，孙秀红，韦相才，等.PCOS大鼠卵巢AMH表达与IR的相关性研究[J].中国免疫学杂志，2014，30（3）：307-311.
[14] 郝栋栋，钟兴明，韦相才.AMHR、INSR及其基因甲基化与PCOS相关病变关系研究进展[J].临床医学，2014，34（1）：114-116.
[15] 颜秀敏，刘凯亮，高心雨，等.不同剂量大豆异黄酮对多囊卵巢综合征大鼠的干预效果研究[J].实用妇产科杂志，2020，36（8）：626-630.
[16] 潘紫萌，侯丽辉，李妍，等.AMH水平与不同证型多囊卵巢综合征各临床指标的差异及相关性分析[J].医学研究杂志，2019，48（8）：74-79.
[17] 黄春月，侯丽辉，杨光，等.抗米勒管激素水平与多囊卵巢综合征患者代谢指标的相关性分析[J].世界中医药，2021，16（14）：2171-2176.
[18] 徐海霞，朱春兰，唐虹.艾灸联合中药对多囊卵巢综合征不孕症患者卵巢储备功能的影响[J].上海针灸杂志，2021，40（5）：571-575.
[19] 黄驰，张稳健.中药补天葵方联合炔雌醇环丙孕酮片对脾虚痰湿证的多囊卵巢综合征患者卵巢功能及血清抗缪勒管激素的影响[J].世界临床药物，2021，42（5）：375- 380.
[20] Tso LO，Costello MF，Albuquerque LET，et al. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome [J]. Cochrane Database Syst Rev，2020，12（12）：CD006105.
[21] 叶志青，周金和.二甲双胍对多囊卵巢综合征大鼠胰岛素抵抗的改善作用[J].中国临床药理学杂志，2021，37（4）：401-404.
[22] 梁未雯，赵永新，周英，等.中医调周法联合生酮饮食治疗肾虚痰湿型多囊卵巢综合征临床观察[J].光明中医，2022，37（7）：1126-1129.
[23] 马郡，阮祥燕，许仲婷，等.资癸女贞胶囊对卵巢储备功能减退女性妊娠结局的影响[J].首都医科大学学报，2023， 44（4）：540-543.
[24] Tsepelidis S，Devreker F，Demeestere I，et al. Stable serum levels of anti-Müllerian hormone during the menstrual cycle：a prospective study in normo-ovulatory women [J]. Hum Reprod，2007，22（7）：1837-1840.
[25] 刘丽杰.雄烯二酮、促黄体激素和胰岛素对卵巢颗粒细胞分泌抗苗勒管氏激素水平的影响[D].杭州：浙江大学，2012.
[26] Broekmans FJ，Visser JA，Laven JS，et al. Anti-Müllerian hor- mone and ovarian dysfunction [J]. Trends Endocrinol Metab， 2008，19（9）：340-347.
[27] Han Q，Wang J，Li W，et al. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome [J]. Microbiome，2021，9（1）：101-116.
[28] Teede H，Misso M，Tassone EC，et al. Anti-Müllerian Hormone in PCOS：A Review Informing International Guidelines [J]. Trends Endocrinol Metab，2019，30（7）：467-478. |
|
|
|
